90 related articles for article (PubMed ID: 8314339)
1. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.
Berumen J; Casas L; Segura E; Amezcua JL; Garcia-Carranca A
Int J Cancer; 1994 Mar; 56(5):640-5. PubMed ID: 8314339
[TBL] [Abstract][Full Text] [Related]
2. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
3. Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas.
Casas L; Galvan SC; Ordoñez RM; Lopez N; Guido M; Berumen J
Int J Cancer; 1999 Nov; 83(4):449-55. PubMed ID: 10508478
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis.
Kalantari M; Karlsen F; Kristensen G; Holm R; Hagmar B; Johansson B
Int J Gynecol Pathol; 1998 Apr; 17(2):146-53. PubMed ID: 9553812
[TBL] [Abstract][Full Text] [Related]
5. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer.
Berumen J; Unger ER; Casas L; Figueroa P
Hum Pathol; 1995 Jun; 26(6):676-81. PubMed ID: 7774900
[TBL] [Abstract][Full Text] [Related]
6. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
7. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa.
Badaracco G; Venuti A
Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656
[TBL] [Abstract][Full Text] [Related]
8. Presence of genetic rearrangements in E1/E2 regions of episomal HPV 16 isolates from cervical carcinomas 5-8.
Dong X; Zhou W; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):5-8. PubMed ID: 11503015
[TBL] [Abstract][Full Text] [Related]
9. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
10. Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions.
Das Ghosh D; Bhattacharjee B; Sen S; Premi L; Mukhopadhyay I; Chowdhury RR; Roy S; Sengupta S
PLoS One; 2012; 7(9):e44678. PubMed ID: 22970286
[TBL] [Abstract][Full Text] [Related]
11. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
12. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
13. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness.
Badaracco G; Venuti A; Sedati A; Marcante ML
J Med Virol; 2002 Aug; 67(4):574-82. PubMed ID: 12116007
[TBL] [Abstract][Full Text] [Related]
14. Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases.
Mori S; Kusumoto-Matsuo R; Ishii Y; Takeuchi T; Kukimoto I
Virol J; 2014 Jan; 11():11. PubMed ID: 24456830
[TBL] [Abstract][Full Text] [Related]
15. Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type.
Terry G; Ho L; Cuzick J
Int J Cancer; 1997 Nov; 73(5):651-5. PubMed ID: 9398041
[TBL] [Abstract][Full Text] [Related]
16. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.
Grinstein E; Wernet P; Snijders PJ; Rösl F; Weinert I; Jia W; Kraft R; Schewe C; Schwabe M; Hauptmann S; Dietel M; Meijer CJ; Royer HD
J Exp Med; 2002 Oct; 196(8):1067-78. PubMed ID: 12391018
[TBL] [Abstract][Full Text] [Related]
18. HPV infection in cervical-cancer cases in Russia.
Samoylova EV; Shaikhaiev GO; Petrov SV; Kisseljova NP; Kisseljov FL
Int J Cancer; 1995 May; 61(3):337-41. PubMed ID: 7729945
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women.
Bhattacharjee B; Sengupta S
Gynecol Oncol; 2006 Feb; 100(2):372-8. PubMed ID: 16246404
[TBL] [Abstract][Full Text] [Related]
20. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein.
Böhm S; Wilczynski SP; Pfister H; Iftner T
Int J Cancer; 1993 Nov; 55(5):791-8. PubMed ID: 8244576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
